- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03604497
Using Bluetooth Beacon Technology to Reduce Distracted Pedestrian Behavior
Over 4,800 American pedestrians die annually, a figure that is current increasing. One hypothesized reason for the increasing trend in pedestrian injuries and deaths is the role of mobile technology in distracting both pedestrians and drivers. The investigators propose to develop and then evaluate Bluetooth beacon technology as a means to alert and warn pedestrians when they are approaching dangerous intersections, reminding them to attend to the traffic environment and cross the street safely rather than engaging with mobile technology. One aspect of the research will involve a crossover research trial to evaluate efficacy of the program.
Bluetooth beacons are very small (about the size of a dime) and inexpensive (~$20 range) devices that broadcast information unidirectionally (beacon to smartphone) within a closed proximal network. The investigators propose placing beacons at intersection corners (e.g., on signposts) frequently trafficked by urban college students. The beacons will transmit to an app installed on users' smartphones, signaling users to attend to their environment and cross the street safely. The app will be developed to be flexible based on user preferences; for research purposes, the app also will download data concerning the users' behavior while crossing the street. The crossover trial will evaluate the app with a sample of about 411 young adults whose behavior is monitored for: (a) 3 weeks without the app being activated, (b) 3 weeks with the app activated, and then (c) 6 weeks without the app activated to assess retention of behavior. Throughout the 12 week period, the investigators will monitor user behavior at multiple intersections around campus, along with gathering self-report questionnaire perceptions and behavior at baseline and 12-week post-intervention assessments.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- UAB Youth Safety Lab, University of Alabama at Birmingham
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- individuals who cross streets on the UAB campus at least twice daily
- ownership of an Android phone
- willingness to install the app on phone
- ability to communicate in English
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: beacon alerts
active intervention - participants are receiving alerts to warn them about distracted pedestrian behavior near intersections
|
alerts via unidirectional communication from beacons to smartphones when smartphones are approaching pedestrian crossing at activated intersection
|
|
No Intervention: no alerts baseline
baseline - participants do not receive any alerts on their mobile smartphone when near intersections
|
|
|
Other: no alerts retention
retention phase - alerts have stopped after active intervention and behavior is monitored to test retention of learned behavior
|
no alerts will appear, but we will measure retention of behavior learned during the active intervention stage
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Street Crossings Distracted
Time Frame: 12 weeks
|
percentage of street-crossings participants is distracted while crossing streets in intersections involved in the study, as measured electronically by smartphone behavior near those intersections.
Electronic measurement was based on x-y-z coordinates of the smartphone during the crossing, as assessed and stored in the participants' phone storage.
|
12 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- R21HD095270 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health Behavior
-
Holbaek SygehusCompletedHealth Behavior | Health Knowledge, Attitudes, Practice | Health-Related Behavior | Health LiteracyDenmark
-
Penn State UniversityCompletedBehavior, HealthUnited States
-
Henry Ford Health SystemUniversity of Kansas; University of Maryland, College ParkActive, not recruiting
-
Istinye UniversityRecruitingHealth-Related BehaviorTurkey (Türkiye)
-
University of Texas Rio Grande ValleyHealth and Human Services Commission (HHSC); Pharr-San Juan-Alamo Independent... and other collaboratorsCompletedHealth-Related BehaviorUnited States
-
University of PrimorskaUniversity of Ljubljana, Faculty of Social Sciences; Ministry of Defence, SloveniaActive, not recruitingHealth-Related BehaviorSlovenia
-
Boston Children's HospitalAllan & Gill Gray FoundationCompletedSleep | Health-Related BehaviorUnited States
-
University of LisbonRecruitingOral Health Behavior Change | Oral Health Care | Oral Health Self-efficacyPortugal
-
Boston Children's HospitalRecruitingSleep | Health-Related BehaviorUnited States
-
Universiti Teknologi MaraUniversiti Putra Malaysia; Ministry of Health, Malaysia; Institute for Health... and other collaboratorsRecruitingHealth Attitude | Health Behavior | Knowledge, Attitudes, Practice | Health Knowledge, Attitudes, Practice | Health-Related Behavior | Behavior, Health | Attitude to Health | Preparedness | OutbreaksMalaysia
Clinical Trials on beacon alerts
-
ETH ZurichInsel Gruppe AG, University Hospital BernNot yet recruitingMortality | Respiratory Failure | Circulatory Failure | Organ Dysfunction | Organ Failure, MultipleSwitzerland
-
Andromeda SurgicalRecruitingBenign Prostatic HyperplasiaNew Zealand, Chile
-
MicroOptxTerminatedGlaucomaUnited States, Canada
-
Royal Brompton & Harefield NHS Foundation TrustImperial College London; Aalborg University; Mermaid Care A/SUnknownRespiratory Insufficiency | Mechanical Ventilation Complication | Critical Care | Respiration, Artificial | Intensive Care (ICU) MyopathyUnited Kingdom
-
University of Wisconsin, MadisonCompletedAge-Related Macular Degeneration | Geographic AtrophyUnited States
-
Imperial College LondonMedical University of Vienna; Queen's University, Belfast; Université d'Auvergne and other collaboratorsCompletedAcute Respiratory Distress SyndromeAustria, France, United Kingdom
-
VA Boston Healthcare SystemOregonCompletedUse of Sleep MedicationsUnited States
-
San Raffaele UniversityRecruitingColorectal Cancer | Lynch Syndrome | Colo-rectal Cancer | Colon Adenoma | Colon Disease | MLH1 Gene Mutation | Adenoma Colon | Colon Neoplasm | Mismatch Repair Deficiency | Lynch Syndrome I (Site-specific Colonic Cancer) | MSH2 Gene Mutation | MSH6 Gene Mutation | PMS2 Gene Mutation | EPCAM Gene Mutation | Lynch Syndrome... and other conditionsItaly
-
National Institute of Allergy and Infectious Diseases...Harvard Medical School (HMS and HSDM); Massachusetts General HospitalCompletedHIV InfectionsUnited States
-
Ohio State UniversityNational Center for Advancing Translational Sciences (NCATS)Active, not recruitingMechanical VentilationUnited States